Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3
- PMID: 15940266
- DOI: 10.1038/sj.onc.1208714
Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3
Abstract
The PML gene of acute promyelocytic leukemia (APL) encodes a cell-growth and tumor suppressor. PML localizes to discrete nuclear bodies (NBs) that are disrupted in APL cells, resulting from a reciprocal chromosome translocation t (15;17). Here we show that the nuclear localization of PML is also regulated by SUMO-3, one of the three recently identified SUMO isoforms in human cells. SUMO-3 bears similar subcellular distribution to those of SUMO-1 and -2 in the interphase nuclear body, which is colocalized with PML protein. However, both SUMO-2 and -3 are also localized to nucleoli, a region lacking SUMO-1. Immunoprecipitated PML protein bears SUMO-3 moiety in a covalently modified form, supporting the notion that PML is conjugated by SUMO-3. To determine the functional relevance of SUMO-3 conjugation on PML molecular dynamics, we suppressed SUMO-3 protein expression using a siRNA-mediated approach. Depletion of SUMO-3 markedly reduced the number of PML-containing NBa and their integrity, which is rescued by exogenous expression of SUMO-3 but not SUMO-1 or SUMO-2. The specific requirement of SUMO-3 for PML nuclear localization is validated by expression of SUMO-3 conjugation defective mutant. Moreover, we demonstrate that oligomerization of SUMO-3 is required for PML retention in the nucleus. Taken together, our studies provide first line of evidence showing that SUMO-3 is essential for PML localization and offer novel insight into the pathobiochemistry of APL.
Similar articles
-
Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.Oncogene. 2007 Mar 8;26(11):1557-66. doi: 10.1038/sj.onc.1209923. Epub 2006 Aug 21. Oncogene. 2007. PMID: 16924230
-
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.EMBO J. 1998 Jan 2;17(1):61-70. doi: 10.1093/emboj/17.1.61. EMBO J. 1998. PMID: 9427741 Free PMC article.
-
ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.Exp Cell Res. 2006 Nov 15;312(19):3739-51. doi: 10.1016/j.yexcr.2006.06.037. Epub 2006 Aug 14. Exp Cell Res. 2006. PMID: 17027752
-
[Research advances on function of promyelocytic leukemia (PML) protein].Ai Zheng. 2003 Dec;22(12):1359-62. Ai Zheng. 2003. PMID: 14693070 Review. Chinese.
-
Role and fate of PML nuclear bodies in response to interferon and viral infections.Oncogene. 2001 Oct 29;20(49):7274-86. doi: 10.1038/sj.onc.1204854. Oncogene. 2001. PMID: 11704856 Review.
Cited by
-
PML Degradation: Multiple Ways to Eliminate PML.Front Oncol. 2013 Mar 22;3:60. doi: 10.3389/fonc.2013.00060. eCollection 2013. Front Oncol. 2013. PMID: 23526763 Free PMC article.
-
Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction.Nat Rev Neurosci. 2007 Dec;8(12):948-59. doi: 10.1038/nrn2276. Nat Rev Neurosci. 2007. PMID: 17987030 Free PMC article. Review.
-
A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.Int J Biol Sci. 2010 Jan 12;6(1):51-67. doi: 10.7150/ijbs.6.51. Int J Biol Sci. 2010. PMID: 20087442 Free PMC article. Review.
-
Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.PLoS One. 2022 May 20;17(5):e0268835. doi: 10.1371/journal.pone.0268835. eCollection 2022. PLoS One. 2022. PMID: 35594310 Free PMC article.
-
The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.Mol Biol Cell. 2011 Jan 1;22(1):78-90. doi: 10.1091/mbc.E10-06-0504. Epub 2010 Dec 9. Mol Biol Cell. 2011. PMID: 21148299 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous